Nutra Pharma Corp.
NPHC
$0.00
$0.000.00%
OTC PK
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -107.52% | -148.25% | 56.77% | -111.82% | 49.01% |
| Total Depreciation and Amortization | -55.51% | 16.82% | 12.33% | 0.41% | 131.13% |
| Total Amortization of Deferred Charges | -83.52% | -80.15% | -77.45% | -52.62% | 40.93% |
| Total Other Non-Cash Items | 100.96% | 102.70% | -73.16% | 102.85% | -65.36% |
| Change in Net Operating Assets | -103.24% | -14.90% | -98.83% | 237.96% | 672.36% |
| Cash from Operations | -244.81% | 49.06% | 34.41% | 64.06% | 76.89% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -30.64% | 6.67% | 350.00% | 529.17% |
| Cash from Investing | 62.33% | -30.64% | 6.67% | 116.13% | 415.95% |
| Total Debt Issued | -34.79% | -10.36% | -32.55% | -42.95% | -15.57% |
| Total Debt Repaid | 68.20% | -19.51% | 28.20% | -0.42% | -366.36% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4,004.00% | -52.44% | -34.17% | -64.96% | -99.16% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -- | -- | -100.00% |